Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge.

d-Pen2,d-Pen5 enkephalin (DPDPE) is one of the most selective synthetic peptide agonists targeting the δ-opioid receptor. Three cyclic analogues of DPDPE containing a xylene bridge in place of disulfide bond have been synthesized and fully characterized as opioid receptors agonists. The in vitro activity was investigated showing a good affinity of 7a-c for μ- and δ-receptors. In vivo biological assays revealed that 7b is the most potent analogue with the ability to maintain high level of analgesia from 15 to 60 min following intracerebroventricular (i.c.v.) administration, whereas DPDPE was slightly active until 45 min. Compound 7b induced long lasting analgesia also after subcutaneous administration, whereas DPDPE was inactive.

[1]  J. Crow.  Biomedicine: Move over, morphine , 2016, Nature.

[2]  K. Hettiarachchi,et al.  Characterization of cyclic peptides containing disulfide bonds. , 2015, Journal of pharmaceutical and biomedical analysis.

[3]  Anton Barty,et al.  Structural basis for bifunctional peptide recognition at human δ-Opioid receptor , 2015, Nature Structural &Molecular Biology.

[4]  Mireia Carcolé,et al.  Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[5]  E. Novellino,et al.  Novel cyclic biphalin analogue with improved antinociceptive properties. , 2014, ACS medicinal chemistry letters.

[6]  G. Pasternak.  Opioids and their receptors: Are we there yet? , 2014, Neuropharmacology.

[7]  R. Bodnar.  Endogenous opiates and behavior: 2012 , 2013, Peptides.

[8]  P. Hänninen,et al.  A homogeneous single-label quenching resonance energy transfer assay for a δ-opioid receptor-ligand using intact cells. , 2013, The Analyst.

[9]  Jean‐François Hernandez,et al.  Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations. , 2013, Journal of medicinal chemistry.

[10]  J. Cornish,et al.  Synthesis and evaluation of disulfide bond mimetics of amylin-(1-8) as agents to treat osteoporosis. , 2012, Bioorganic & medicinal chemistry.

[11]  J. V. van Maarseveen,et al.  Synthesis of water-soluble scaffolds for peptide cyclization, labeling, and ligation. , 2012, Organic letters.

[12]  V. Hruby,et al.  New potent biphalin analogues containing p-fluoro-l-phenylalanine at the 4,4′ positions and non-hydrazine linkers , 2011, Amino Acids.

[13]  James R. Baker,et al.  Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides , 2010, Journal of the American Chemical Society.

[14]  O. Pol,et al.  The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  A. Piscopo,et al.  New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation. , 2008, Pharmacological research.

[16]  M. Yar,et al.  An annulation reaction for the synthesis of morpholines, thiomorpholines, and piperazines from beta-heteroatom amino compounds and vinyl sulfonium salts. , 2008, Angewandte Chemie.

[17]  D. Tourwé,et al.  Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles , 2007, Brain Research Bulletin.

[18]  V. Hruby,et al.  Synthesis of Stable and Potent δ/μ Opioid Peptides: Analogues of H-Tyr-c[d-Cys-Gly-Phe-d-Cys]-OH by Ring-Closing Metathesis , 2007 .

[19]  I. Alves,et al.  New paradigms and tools in drug design for pain and addiction , 2006, The AAPS Journal.

[20]  Peter Timmerman,et al.  Rapid and Quantitative Cyclization of Multiple Peptide Loops onto Synthetic Scaffolds for Structural Mimicry of Protein Surfaces , 2005, Chembiochem : a European journal of chemical biology.

[21]  P. Milanov,et al.  Opioid profiles of Cys2-containing enkephalin analogues. , 2004, European journal of pharmacology.

[22]  M. Meldal,et al.  Bicyclic Organo‐Peptides as Selective Carbohydrate Receptors: Design, Solid‐phase Synthesis, and on‐bead Binding Capability , 2004 .

[23]  Tatsuo Yamamoto,et al.  Involvement of Nitric Oxide in Peripheral Antinociception Mediated by kappa- and delta-Opioid Receptors , 1998, Anesthesia and analgesia.

[24]  G. Tóth,et al.  Met5‐enkephalin‐Arg 6‐Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain , 1997, Journal of neuroscience research.

[25]  Victor J. Hruby,et al.  X-ray Structure of [D-Pen2,D-Pen5]enkephalin, a Highly Potent, .delta. Opioid Receptor-Selective Compound: Comparisons with Proposed Solution Conformations , 1994 .

[26]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[27]  T. Burks,et al.  Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test. , 1987, The Journal of pharmacology and experimental therapeutics.

[28]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[29]  V. Hruby,et al.  Rational approach to the design of bioactive peptidomimetics: Recent developments in opioid agonist peptides , 2015 .

[30]  G. Scarabelli,et al.  Bioactive conformations of two seminal delta opioid receptor penta-peptides inferred from free-energy profiles. , 2014, Biopolymers.

[31]  Move Over Morphine? , 1985 .